POSIFLO Trademark

Trademark Overview

On Thursday, April 7, 2011, a trademark application was filed for POSIFLO with the United States Patent and Trademark Office. The USPTO has given the POSIFLO trademark a serial number of 85288534. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 2, 2014. This trademark is owned by Glaxo Group Limited. The POSIFLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment, and/or alleviation of respiratory disorders
posiflo

General Information

Serial Number85288534
Word MarkPOSIFLO
Filing DateThursday, April 7, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 2, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment, and/or alleviation of respiratory disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 11, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, June 2, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 2, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, October 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 24, 2013EXTENSION 4 GRANTED
Monday, October 21, 2013EXTENSION 4 FILED
Monday, October 21, 2013TEAS EXTENSION RECEIVED
Saturday, May 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2013EXTENSION 3 GRANTED
Monday, April 29, 2013EXTENSION 3 FILED
Monday, April 29, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, September 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 21, 2012EXTENSION 2 GRANTED
Thursday, September 20, 2012EXTENSION 2 FILED
Friday, September 21, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 20, 2012TEAS EXTENSION RECEIVED
Saturday, March 17, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 15, 2012EXTENSION 1 GRANTED
Thursday, March 15, 2012EXTENSION 1 FILED
Thursday, March 15, 2012TEAS EXTENSION RECEIVED
Tuesday, November 1, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 6, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2011PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 27, 2011ASSIGNED TO LIE
Wednesday, July 6, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2011EXAMINER'S AMENDMENT ENTERED
Wednesday, July 6, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 6, 2011EXAMINERS AMENDMENT E-MAILED
Wednesday, July 6, 2011EXAMINERS AMENDMENT -WRITTEN
Thursday, June 30, 2011ASSIGNED TO EXAMINER
Monday, April 11, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 11, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

posiflo alleviation respiratory disorders treatment prevention preparations substances pharmaceutical